Industry rejects call for transparency over use of strategy that can delay competition from generic medicines
Big Pharma fights patent disclosure demand from investors
Recent Posts
- The legacy of a compassionate reformist pope
- Israeli intelligence chief says Netanyahu told him to defy top court
- White House stands behind Hegseth over new Signal chat allegations
- China’s CATL claims to have overtaken BYD on 5-minute EV battery charging time
- Trump, Vance and the attack on American universities
